Private equity firm Ampersand Capital Partners has sold medical device design company MedVenture Technology to Helix Medical, a manufacturer for the medical device and healthcare industries. Established in 1998, MedVenture is headquartered in the Louisville, Kentucky metropolitan area and employs over 260 associates. MedVenture develops and manufactures minimally invasive surgical

Maranon Capital has made an investment in Performance Health and Wellness Holdings to support the acquisition of the business by Gridiron Capital and Performance Health’s management team. Maranon arranged and led a syndicate that provided mezzanine debt and an equity co-investment. Headquartered in Akron, Ohio, Performance Health is a designer,

Preqin’s initial public offering pipeline data reveals that there are currently 42 private equity and venture capital-backed companies globally set to list in the coming weeks, seeking to raise USD8.4bn in public offerings.   Twenty-four of these companies are buyout-backed, and a further 18 VC-backed companies have currently filed for an

Funds advised by European private equity fund PAI Partners are to purchase a 78.39 per cent stake in Marcolin, an Italian eyewear manufacturer, at a price of EUR4.25 per share from family and private owners in a proprietary primary LBO transaction in one of its core investment sectors. On completion,

Private equity firm Advent International is to acquire KMD, a Danish IT services and software company, from EQT and ATP. Advent’s investment is subject to customary regulatory approval and is expected to complete by year-end.   Founded in 1972, the company has a long track record as a trusted partner

Ombu Group, a new UK investment company focused on backing and building UK technology companies, has invested a further GBP5m into Open Energi. This increases Ombu’s total commitment of growth capital into the company to GBP9m and will enable Open Energi to expand its business in the UK and overseas.

HIG Capital’s European affiliate, HIG Europe, is to acquire shares representing 49.99 per cent of the capital of Vértice 360 Servicios Audiovisuales (VSA) – until now fully owned by Vértice 360º – for a total of EUR16m. The investment will take place through a capital increase, following which the remaining

European private equity firm Cinven has acquired the Amdipharm Group, the family-owned international niche pharmaceuticals business, for a total consideration of GBP367m. Amdipharm will operate initially as a standalone business but, over time, Cinven will look to merge Amdipharm with its existing portfolio company, Mercury Pharma, which it acquired in